RARE
CRITICALUltragenyx Pharmaceutical Inc.
CIK: 0001515673
Last activity: 3 weeks ago
Financial Metrics
As of Dec 31, 2025 (10-K)
Insider Roster (7 total, 7 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
|
KAKKIS EMIL D
President & CEO
|
0 | 1 | -$1.24M |
658,994 shares
$15.03M
|
|
Horn Howard
Chief Financial Officer
|
0 | 6 | -$484K |
85,034 shares
$1.90M
|
|
Parschauer Karah Herdman
EVP and Chief Legal Officer
|
0 | 3 | -$394K |
66,820 shares
$1.51M
|
|
Harris Erik
EVP & Chief Commercial Officer
|
0 | 1 | -$240K |
89,515 shares
$2.04M
|
|
Pinion John Richard
See Remarks
|
0 | 1 | -$229K |
110,026 shares
$2.51M
|
|
Crombez Eric
EVP and Chief Medical Officer
|
0 | 1 | -$160K |
76,301 shares
$1.74M
|
|
Huizenga Theodore Alan
SVP, Chief Accounting Officer
|
0 | 2 | -$40K |
48,670 shares
$1.11M
|
Recent Transactions
3,508 shares @ $22.67
$80K
Mar 10, 2026
6,018 shares @ $21.40
$129K
Mar 6, 2026
1,635 shares @ $22.40
$37K
Mar 3, 2026
54,404 shares @ $22.80
$1.24M
Mar 2, 2026
10,539 shares @ $22.80
$240K
Mar 2, 2026
10,029 shares @ $22.80
$229K
Mar 2, 2026
8,135 shares @ $22.80
$185K
Mar 2, 2026
7,029 shares @ $22.80
$160K
Mar 2, 2026
5,290 shares @ $22.80
$121K
Mar 2, 2026
3,119 shares @ $22.54
$70K
Mar 2, 2026
1,632 shares @ $22.80
$37K
Mar 2, 2026
3,061 shares @ $23.56
$72K
Feb 2, 2026
3,150 shares @ $22.84
$72K
Jan 2, 2026
85 shares @ $34.38
$3K
Dec 29, 2025
3,081 shares @ $36.38
$112K
Dec 10, 2025
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.